Stock Events

Stock Events

Prelude Therapeutics (PRLD) Q2 2026 Earnings

12MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.47

-0.35

-0.24

-0.13

Details

Expected EPS

-0.2525

Actual EPS

-0.13

Surprise EPS

0.12

Surprise Percent

+48.51%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.13 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.